World Professional Association for Transgender Health (WPATH), October 2022 Following five-years of rigorous scientific effort by more than 120 health care clinical and academic professionals across the globe, the World Professional Association for Transgender Health (WPATH) has released the Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 (SOC8). Building upon...
SHINE SA, August 2022 Families in Transition: Information Sessions (Face-to-Face and Online) for Parents and Carers of Trans and Gender Diverse Young People Who are these information sessions for? Parents and carers of trans, gender diverse, and questioning (TGD) young people between 12-25 years What will we cover? In a two-hour session, lived experience workers will discuss: • Gender and gender...
South Australian Rainbow Advocacy Alliance (SARAA), July 2022 On 21 July 2022 trans community advocates and SARAA met with Health Minister Chris Picton MP to present signatures from over 150 South Australians calling for timely and accessible gender affirming healthcare. SA Health released their draft State-wide Gender Diversity Model of Care later that day. It sets out plans for: continued...
SHINE SA, 2022 SHINE SA’s Gender Wellbeing Service is a free, confidential mental health service for people who are questioning their gender identity or identify as trans or gender diverse. (This service provides psychological therapies, peer support, general information and support within the metropolitan area of Adelaide. If you would like to see if you live or work within the Adelaide...
Aboriginal Health and Medical Research Council of New South Wales, 2020 This fact sheet offers a question-and-answer format to help health practitioners, Aboriginal Health Workers, doctors, nurses or other people working with gender diverse patients to better understand how to talk to and connect with sistergirls, brotherboys and other patients in an appropriate way. Please note: this document...
nam/aidsmap, 7 September 2020 A study in which 24 trans women and 24 trans men who were taking gender-affirming hormone therapy were directly observed to take a daily dose of the standard formulation of the HIV prevention medication PrEP found that the levels of the two PrEP drugs tenofovir and emtricitabine were similar to the levels seen in similar cis men and women, and were all above levels...